Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center has participated in 3 clinical trials.
Therapeutic areas: Multiple Myeloma, Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Chronic Lymphocytic Leukemia (CLL).
Sponsors: Janssen Scientific Affairs, LLC, EMD Serono Research & Development Institute, Inc., Pharmacyclics LLC..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center has 3 clinical trials on record. Their work covers Multiple Myeloma, Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Chronic Lymphocytic Leukemia (CLL).
Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.